Legislative (DQSA, USP)
DQSA Law
Read the Drug Quality and Security Act (DQSA) law which grants the FDA regulatory authority over compounded drugs. See the law
DQSA Webinar
Mobius teamed up with ASORN to present an informative webinar discussing DQSA and how it affects your business, featuring two industry experts answering questions and providing important details about the law. Watch the DQSA Compliance Webinar
DQSA Risks of Pharmacy Compounding
This important document thoroughly discusses the risks associated with compounded drugs. Learn more
USP Guidance
Hazardous drugs – handling in healthcare settings. Read about the important requirements for handling hazardous drugs to protect patient, personnel and environment. Read More
USP 800 NIOSH Alert
Both traditional medications and bioengineered drugs can be hazardous to health care workers who must handle them. This NIOSH Alert will help make workers and employers more aware of these hazards and provide the tools for preventing exposures. Read More
Mitomycin
ASORN Wall Chart
Top tips for safe handling, use, and disposal of Ophthalmic Mitomycin-C. Provide by American Society of Ophthalmic Registered Nurses(ASORN) for educational purposes. Download it
ASORN MMC Guide
Independent authors’ guidelines for the safe use and handling of mitomycin C in ophthalmic practices. Learn more
Anesthetics
IJO Article – Hyaluronidase Clinical Trial
Results of a clinical trial investigating the effect of hyaluronidase usage on the quality of sub-Tenon’s anesthesia for phacoemulsification. Read the article.
Hyaluronidase Trial Graph
Graph representing the results from the Clinical Trial of Hyaluronidase and it’s benefits. See What is Hyaluronidase used for?